Skip to main content

Table 1 Patient’s clinical characteristics

From: THeragnostic utilities for neoplastic DisEases of the rectum by MRI guided radiotherapy (THUNDER 2) phase II trial: interim safety analysis

Patients characteristics

Number

32 (100%)

Median Age years (range)

67 (41–94)

Gender

Male

Female

18 (56.3)

14 (43.7)

ECOG

0

1

26 (81.3)

6 (18.7)

Smoking status

Yes

Not

8 (25)

24 (75)

Comorbidities

Hypertension

Type 2 diabetes

Chronic obstructive pulmonary disease

Benign prostatic hyperplasia

Hypothyroidism

Glaucoma

Cardiological comorbidities (valvulopathy, atrial fibrillation, transient ischaemic attack, chronic ischaemic heart disease)

13 (40.6)

4 (12.5)

3 (9.4)

4 (12.5)

4 (12.5)

2 (6.3)

4 (12.5)

Tumor location

High

Middle

Low

2 (6.3)

11 (34.4)

19 (59.3)

cT stage

2

3

4

4 (12.5)

26 (81.3)

2 (6.2)

cN stage

0

1

2

9 (28.1)

16 (50)

7 (21.93)

Clinical stage

II

III

9 (28.1)

23 (71.9)